D5 dopamine receptor regulation of phospholipase D

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Yang, Zhiwei ^a   Asico, Laureano D ^a   Yu, Peiying ^a   Wang, Zheng ^a   Jones, John E ^a   Bai, Ren Kui ^a   Sibley, David R ^b   Felder, Robin A ^c   Jose, Pedro A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Hypertension

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FENOLDOPAM; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; DOPAMINE 1 RECEPTOR; DRD5 PROTEIN, HUMAN; DRD5 PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPERTENSION; KIDNEY; KIDNEY TUBULE EPITHELIUM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; ANIMAL; ARTICLE; BLOOD PRESSURE; CELL LINE; CHO CELL; CRICETULUS; ENZYMOLOGY; GENETICS; HAMSTER; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TISSUE DISTRIBUTION;

ANIMALS; BLOOD PRESSURE; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; KIDNEY; MICE; MICE, KNOCKOUT; PHOSPHOLIPASE D; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 11144264574     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00627.2004     Document Type: Conference Paper

References (48)

1. Andresen BT, Jackson EK, and Romero GG. Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension 37: 635-639, 2001.
2. Cheng HF, Becker BN, and Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 97: 2745-2752, 1996.
3. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, and Frohman MA. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 7: 191-201, 1997.
4. Dhalla NS, Xu YJ, Sheu SS, Tappia PS, and Panagia V. Phosphatidic acid: a potential signal transducer for cardiac hypertrophy. J Mol Cell Cardiol 29: 2865-2871, 1997.
5. Exton JH. Regulation of phospholipase D. FEBS Lett 531: 58-61, 2002.
6. Felder CC, Jose PA, and Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phopholipase-C activity independent of adenylate cyclase. J Pharmocol Exp Ther 248: 171-175, 1989.
7. Freeman EJ, Ferrario CM, and Tallant EA. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens 8: 1105-1111, 1995.
8. Gomez-Cambronero J and Keire P. Phospholipase D: a novel major player in signal transduction. Cell Signal 10: 387-397, 1998.
9. Hammond SM, Jenco JM, Nakashima S, Cadwallader K, Gu Q, Cook S, Nozawa Y, Prestwich GD, Frohman MA, and Morris AJ. Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha. J Biol Chem 272: 3860-3868, 1997.
10. Hartner A, Cordasic N, Klanke B, Veelken R, and Hilgers KF. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrol Dial Transplant 18: 1999-2004, 2003.
11. Hickman-Davis JM. Implications of mouse genotype for phenotype. News Physiol Sci 16: 19-22, 2001.
12. 5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22: 10801-10810, 2002.
13. Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR, and Crawley JN. Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci 115: 1129-1144, 2001.
14. Hussain T and Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 32: 187-197, 1998.
15. Jang MJ, Lee MJ, Park HY, Bae YS, Min do S, Ryu SH, and Kwak JY. Phosphorylation of phospholipase D1 and the modulation of its interaction with RhoA by cAMP-dependent protein kinase. Exp Mol Med 36: 172-178, 2004.
16. Jenco JM, Rawlingson A, Daniels B, and Morris AJ. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochemistry 37: 4901-4909, 1998.
17. Jose PA, Eisner GM, and Felder RA. The renal dopamine receptors in health and hypertension. Pharmacol Ther 80: 149-182, 1998.
18. Kim JH, Lee S, Kim JH, Lee TG, Hirata M, Suh PG, and Ryu SH. Phospholipase D2 directly interacts with aldolase via its PH domain. Biochemistry 41: 3414-3421, 2002.
19. Kwak JY and Uhlinger DJ. Downregulation of phospholipase D by protein kinase A in a cell-free system of human neutrophils. Biochem Biophys Res Commun 267: 305-310, 2000.
20. Lee HY, Park JB, Jang IH, Chae YC, Kim JH, Km IS, Suh PG, and Ryu SH. Munc-18-1 inhibits phospholipase D activity by direct interaction in an epidermal growth factor-reversible manner. J Biol Chem 279: 16339-16348, 2004.
21. Lee S, Park JB, Kim JH, Kim Y, Kim JH, Shin KJ, Lee JS, Ha SH, Suh PG, and Ryu SH. Actin directly interacts with phospholipase D, inhibiting its activity. J Biol Chem 276: 28252-28260, 2001.
22. Lee TG, Park JB, Lee SD, Hong S, Kim JH, Kim Y, Yi KS, Bae S, Hannun YA, Obeid LM, Suh PG, and Ryu SH. Phorbol myristate acetate-dependent association of protein kinase C alpha with phospholipase D1 in intact cells. Biochim Biophys Acta 1347: 199-204, 1997.
23. Liscovitch M, Czarny M, Fiucci G, Lavie Y, and Tang X. Localization and possible functions of phospholipase D isozymes. Biochim Biophys Acta 1439: 245-263, 1999.
24. Mamoon AM, Smith J, Baker RC, and Farley JM. Activation of protein kinase A increases phospholipase D activity and inhibits phospholipase D activation by acetylcholine in tracheal smooth muscle. J Pharmacol Exp Ther 291: 1188-1195, 1999.
25. Meier KE, Gibbs TC, Knoepp SM, and Ella KM. Expression of phospholipase D isoforms in mammalian cells. Biochim Biophys Acta 1439: 199-213, 1999.
26. Min DS, Lee KH, Chang JS, Ahn BH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, and Jo YH. Altered expression of phospholipase D1 in spontaneously hypertensive rats. Mol Cell 11: 386-391, 2001.
27. Nakamura S, Shimooku K, Akisue T, Jinnai H, Hitomi T, Kiyohara Y, Ogino C, Yoshida K, and Nishizuka Y. Mammalian phospholipase D: activation by ammonium sulfate and nucleotides. Proc Natl Acad Sci USA 92: 12319-12322, 1995.
28. Redina OE and Frohman MA. Organization and alternative splicing of the murine phospholipase D2 gene. Biochem J 331: 845-851, 1998.
29. Shome K, Rizzo MA, Vasudevan C, Andresen B, and Romero G. The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle AlO cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology 141: 2200-2208, 2000.
30. Sibley DR and Monsma FJ Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci 13: 61-69, 1992.
31. Singh IN, Stromberg LM, Bourgoin SG, Sciorra VA, Morris AJ, and Brindley DN. Ceramide inhibition of mammalian phospholipase D1 and D2 activities is antagonized by phosphatidylinositol 4,5-bisphosphate. Biochemistry 40: 11227-11233, 2001.
32. Slaaby R, Du G, Altshuller YM, Frohman MA, and Seedorf K. Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade. Biochem J 351: 613-619, 2000.
33. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, and Niznik HB. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350: 614-619, 1991.
34. Tiberi M and Caron MG. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269: 27925-27931, 1994.
35. Touyz RM and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015, 2002.
36. Touyz RM and Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34: 976-982, 1999.
37. Touyz RM and Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19: 1245-1254, 2001.
38. Waite M. The PLD superfamily: insights into catalysis. Biochim Biophys Acta 1439: 187-197, 1999.
39. Wang Q, Jolly JP, Surmeier JD, Mullah BM, Lidow MS, Bergson CM, and Robishaw JD. Differential dependence of the D1 and D5 dopamine receptors on the G protein gamma 7 subunit for activation of adenylylcyclase. J Biol Chem 276: 39386-39393, 2001.
40. White BH, Kimura K, and Sidhu A. Inhibition of hormonally induced inositol trisphosphate production in transfected GH4C1 cells: a novel role for the D5 subtype of the dopamine receptor. Neuroendocrinology 69: 209-216, 1999.
41. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
42. Wolfer DP, Crusio WE, and Lipp HP. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25: 336-40, 2002.
43. 1-like receptors. Circulation 101: 2302-2308, 2000.
44. 5 dopamine regulation of phospholipase D and blood pressure in mice (Abstract). Am J Hypertens 15: 174A, 2002.
45. 5 dopamine receptor regulation of NADPH oxidase and blood pressure in mice (Abstract). J Am Soc Nephrol 14: 553A, 2003.
46. Yu P, Asico LD, Eisner GM, Hopfer U, Felder RA, and Jose PA. Renal protein phosphatase 2A activity and spontaneous hypertension in rats. Hypertension 36: 1053-1058, 2000.
47. Zeng C, Luo Y, Asico LD, Hopfer U, Eisner GM, Felder RA, and Jose PA. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 42: 787-792, 2003.
48. Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, Felder RA, and Jose PA. Gα12- and Gαβ-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 41: 604-610, 2003.